Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mega-dose sodium ascorbate for septic shock
ACTRN12625001401448Phase 2Not yet recruiting
- Sponsor
- Florey Institute of Neuroscience and Mental Health
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sodium ascorbate in sepsis and septic shock (2 arms), sponsored by Florey Institute of Neuroscience and Mental Health. Primary endpoint: Feasibility. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
sodium ascorbate
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on ACTRN12625001401448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001401448.